The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. [electronic resource]
Producer: 20010222Description: 286-93 p. digitalISSN:- 0022-1899
- AIDS-Related Opportunistic Infections -- microbiology
- Adult
- Antifungal Agents -- pharmacology
- Candida -- classification
- Candida albicans -- drug effects
- Candidiasis, Oral -- drug therapy
- Candidiasis, Vulvovaginal -- drug therapy
- Drug Resistance, Microbial
- Female
- Fluconazole -- pharmacology
- HIV Seronegativity
- Humans
- Microbial Sensitivity Tests
- Oropharynx -- microbiology
- Risk Factors
- Vagina -- microbiology
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.